4/15
11:04 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
4/10
07:10 am
uncy
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]
Low
Report
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]
4/10
07:03 am
uncy
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Low
Report
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
4/4
08:03 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $9.00 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $9.00 price target on the stock.
4/1
08:09 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
3/28
04:35 pm
uncy
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/28
04:15 pm
uncy
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
Low
Report
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
3/25
07:09 am
uncy
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress [Yahoo! Finance]
3/25
07:03 am
uncy
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress
Medium
Report
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress
3/18
03:10 pm
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
3/14
07:06 am
uncy
Unicycive Announces $50 Million Private Placement [Yahoo! Finance]
High
Report
Unicycive Announces $50 Million Private Placement [Yahoo! Finance]
3/14
07:03 am
uncy
Unicycive Announces $50 Million Private Placement
Low
Report
Unicycive Announces $50 Million Private Placement
3/13
07:03 am
uncy
Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
Medium
Report
Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
3/7
04:23 pm
uncy
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
3/7
04:12 pm
uncy
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)
Low
Report
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)
3/5
08:14 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
3/4
07:17 am
uncy
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients [Yahoo! Finance]
High
Report
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients [Yahoo! Finance]
3/4
07:03 am
uncy
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
Medium
Report
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
2/14
01:16 pm
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $6.00 price target on the stock.
Medium
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $6.00 price target on the stock.
2/14
07:12 am
uncy
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting [Yahoo! Finance]
High
Report
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting [Yahoo! Finance]
2/14
07:03 am
uncy
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
High
Report
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting
2/6
06:36 am
uncy
We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate [Yahoo! Finance]
1/29
07:10 am
uncy
Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference [Yahoo! Finance]
Low
Report
Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference [Yahoo! Finance]
1/29
07:03 am
uncy
Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference
Low
Report
Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference